ACERCA DE ESTE EPISODIO
Early Phase Oncology trials have evolved from simple safety checks to the most scientifically demanding stage of cancer drug development. In this episode of Accelerating Oncology – Inside the EPON Network, host Ken Morrison and guest María García unpack why Phase 1 trials are no longer “entry-level” and why they require a specialized model for success.
Inglés
Estados Unidos
TRANSCRIPCIÓN 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
BUSCAR EPISODIOS ANTERIORES
Buscar episodios anteriores de Accelerating Oncology - Inside the EPON Network.
OTROS EPISODIOS EN ESTE PODCAST
In this episode, we explore why geography is more than a backdrop—it is a strategic lever in early phase oncology trials. From patient access and regulatory timelines to investigator expertise and data governance, every decision about trial placement can accelerate or stall innovation.
Join host Ma…
In this episode of Accelerating Oncology – Inside the EPON Network, host Maria Garcia discusses why partnerships matter in early phase oncology. We’ll also find out what makes an EPON site different and talk about partnership design principles.
Host: María García Requesens, Medical Director Fortre…
Descargo de responsabilidad: El podcast y el arte incluidos en esta página son de Fortrea, que es propiedad de su propietario y no está afiliado ni respaldado por Listen Notes, Inc.
EDITAR
Gracias por ayudar a mantener actualizada la base de datos de podcasts.